Library Logo

Foye's principles of medicinal chemistry / (Record no. 34798)

000 -LEADER
fixed length control field 04642cam a2200397 a 4500
001 - CONTROL NUMBER
control field 3387298
003 - CONTROL NUMBER IDENTIFIER
control field BD-DhUL
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20150121171945.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 010921s2002 paua b 001 0 eng
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2001050327
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0683307371
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)48057043
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)ocm48057043
035 ## - SYSTEM CONTROL NUMBER
System control number (NNC)3387298
040 ## - CATALOGING SOURCE
Original cataloging agency BD-DhUL
Transcribing agency BD-DhUL
Modifying agency OrLoB-B
050 00 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RS403
Item number .P75 2002
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.19
Item number WIF
245 00 - TITLE STATEMENT
Title Foye's principles of medicinal chemistry /
Statement of responsibility, etc. [edited by] David A. Williams, Thomas L. Lemke.
246 30 - VARYING FORM OF TITLE
Title proper/short title Principles of medicinal chemistry
250 ## - EDITION STATEMENT
Edition statement 5th ed.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc. Philadelphia :
Name of publisher, distributor, etc. Lippincott Williams & Wilkins,
Date of publication, distribution, etc. c2002.
300 ## - PHYSICAL DESCRIPTION
Extent xii, 1114 p. :
Other physical details ill. ;
Dimensions 29 cm.
365 ## - TRADE PRICE
Price type code IRS
Price amount 1500.00
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and indexes.
505 00 - FORMATTED CONTENTS NOTE
Title Introduction: Origins of Medicinal Chemistry /
Statement of responsibility William O. Foye --
Miscellaneous information Pt. I.
Title Principles of Drug Discovery --
-- Overview: Drug Design and Development: A Perspective /
Statement of responsibility Michael Williams.
Miscellaneous information 1.
Title Natural Products /
Statement of responsibility Alice M. Clark.
Miscellaneous information 2.
Title Drug Design and Relationship of Functional Groups to Pharmacologic Activity /
Statement of responsibility James J. Knittel and Robin M. Zavod.
Miscellaneous information 3.
Title Molecular Modeling and Drug Design /
Statement of responsibility Eric Billings.
Miscellaneous information 4.
Title Receptors and Drug Action /
Statement of responsibility Timothy J. Maher and David A. Johnson.
Miscellaneous information 5.
Title Drug Design Through Enzyme Inhibition /
Statement of responsibility Stephen G. Kerr.
Miscellaneous information 6.
Title Peptide and Protein Drugs /
Statement of responsibility Michael Mokotoff.
Miscellaneous information 7.
Title Physicochemical and Biopharmaceutical Properties of Drug Substances and Pharmacokinetics /
Statement of responsibility Sunil Jambhekar.
Miscellaneous information 8.
Title Drug Metabolism /
Statement of responsibility David A. Williams.
Miscellaneous information 9.
Title U.S. Drug Regulation: An Overview /
Statement of responsibility Douglas J. Pisano --
Miscellaneous information Pt. II.
Title Pharmacodynamic Agents --
-- Overview: Drug Receptors: A Perspective /
Statement of responsibility David J. Triggle.
Miscellaneous information 10.
Title Drugs Affecting Cholinergic Neurotransmission /
Statement of responsibility Danny L. Lattin and E. Kim Fifer.
505 80 - FORMATTED CONTENTS NOTE
Miscellaneous information 11.
Title Drugs Affecting Adrenergic Neurotransmission /
Statement of responsibility Robert Griffith.
Miscellaneous information 12.
Title Serotonin Receptors and Drugs Affecting Serotonergic Neurotransmission /
Statement of responsibility Richard A. Glennon and Malgorzata Dukat.
Miscellaneous information 13.
Title Local Anesthetics /
Statement of responsibility Matthias C. Lu.
Miscellaneous information 14.
Title Volatile Anesthetics /
Statement of responsibility Timothy J. Maher.
Miscellaneous information 15.
Title Hypnotics /
Statement of responsibility William Soine.
Miscellaneous information 16.
Title Antiseizure Drugs /
Statement of responsibility Barbara W. Leduc.
Miscellaneous information 17.
Title Psychotherapeutic Drugs: Antipsychotic and Anxiolytic Agents /
Statement of responsibility Raymond G. Booth and John L. Neumeyer.
Miscellaneous information 18.
Title Hallucinogens, Stimulants, and Related Drugs of Abuse /
Statement of responsibility Richard A. Glennon.
Miscellaneous information 19.
Title Opioid Analgesics /
Statement of responsibility David S. Fries.
Miscellaneous information 20.
Title Drugs Used to Treat Neuromuscular Disorders: Antiparkinsonian and Spasmolytic Agents /
Statement of responsibility Raymond G. Booth and John L. Neumeyer.
Miscellaneous information 21.
Title Cardiac Agents: Cardiac Glycosides, Antianginal, and Antiarrhythmic Drugs /
Statement of responsibility Ahmed S. Mehanna.
Miscellaneous information 22.
Title Diuretics /
Statement of responsibility Gary O. Rankin.
Miscellaneous information 23.
Title Angiotensin Converting Enzyme Inhibitors, Antagonists and Calcium Blockers /
Statement of responsibility Marc W. Harrold.
505 80 - FORMATTED CONTENTS NOTE
Miscellaneous information 24.
Title Central and Peripheral Sympatholytics and Vasodilators /
Statement of responsibility David A. Williams.
Miscellaneous information 25.
Title Antihyperlipoproteinemics and Inhibitors of Cholesterol Biosynthesis /
Statement of responsibility Marc W. Harrold.
Miscellaneous information 26.
Title Antithrombotics, Thrombolytics, Coagulants and Plasma Extenders /
Statement of responsibility Robert B. Palmer.
Miscellaneous information 27.
Title Insulin and Oral Hypoglycemic Drugs /
Statement of responsibility Robert A. Wiley.
Miscellaneous information 28.
Title Adrenocorticoids /
Statement of responsibility Duane D. Miller, Robert W. Brueggemeier and James T. Dalton.
Miscellaneous information 29.
Title Estrogen, Progestins and Androgens /
Statement of responsibility Robert W. Brueggemeier, Duane D. Miller and James T. Dalton.
Miscellaneous information 30.
Title Thyroid Function and Thyroid Drugs /
Statement of responsibility Ali R. Banijamali.
Miscellaneous information 31.
Title Calcium Homeostasis /
Statement of responsibility Robin M. Zavod.
Miscellaneous information 32.
Title Nonsteroidal Anti-Inflammatory Agents /
Statement of responsibility Ronald F. Borne.
Miscellaneous information 33.
Title Antihistamines and Related Antiallergic and Antiulcer Agents /
Statement of responsibility Wendel L. Nelson.
Miscellaneous information 34.
Title Antibiotics and Antimicrobial Agents /
Statement of responsibility Lester A. Mitscher.
Miscellaneous information 35.
Title Antiparasitic Agents /
Statement of responsibility Thomas L. Lemke.
Miscellaneous information 36.
Title Antifungal Drugs /
Statement of responsibility Robert Griffith and Timothy Tracy.
Miscellaneous information 37.
Title Antimycobacterial Agents /
Statement of responsibility Thomas L. Lemke.
505 80 - FORMATTED CONTENTS NOTE
Miscellaneous information 38.
Title Cancer and Cancer Chemotherapy /
Statement of responsibility Patrick S. Callery and Peter M. Gannett.
Miscellaneous information 39.
Title Antiviral Agents and Protease Inhibitors /
Statement of responsibility Manohar L. Sethi --
Miscellaneous information Pt. III.
Title Recent Advances in Drug Discovery.
Miscellaneous information 40.
Title Pharmaceutical Biotechnology /
Statement of responsibility Robert D. Sindelar.
Miscellaneous information 41.
Title Gene Therapy /
Statement of responsibility Ronald E. Reid.
Miscellaneous information 42.
Title Antisense Therapeutic Agents /
Statement of responsibility Marilyn K. Speedie.
Miscellaneous information 43.
Title Selective Estrogen Receptor Modulators /
Statement of responsibility V. Craig Jordan --
Title pKa Values for Some Drugs and Miscellaneous Organic Acids and Bases; pH Values for Tissue Fluids /
Statement of responsibility David A. Williams.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmaceutical chemistry.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Chemistry, Pharmaceutical.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lemke, Thomas L.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Williams, David A.,
Dates associated with a name 1938-
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Foye, William O.
900 ## - EQUIVALENCE OR CROSS-REFERENCE-PERSONAL NAME [LOCAL, CANADA]
Numeration TOC
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Koha item type Books
Holdings
Price effective from Date last seen Permanent Location Not for loan Date acquired Source of classification or shelving scheme Koha item type Lost status Withdrawn status Copy number Source of acquisition Collection code Damaged status Shelving location Barcode Current Location Full call number
2015-01-212015-01-21Dhaka University Science Library 2005-07-13 Books  2PurchasedNon Fiction General Stacks412604Dhaka University Science Library615.19 WIF
2015-01-212015-01-21Dhaka University Science Library 2005-07-13 Books  1PurchasedNon Fiction General Stacks412603Dhaka University Science Library615.19 WIF
Last Updated on September 15, 2019
© Dhaka University Library. All Rights Reserved|Staff Login